In this article, we will delve into the fascinating world of A-366,833, exploring its origins, evolution and relevance in today's society. From his first appearances to his impact on everyday life, A-366,833 has captured the attention of millions of individuals around the world. Through a deep and detailed analysis, we will examine the different aspects that make it so incredibly interesting and worth exploring. From its possible implications in the future to its meaning in the present, A-366,833 has left an indelible mark on history, and it is essential to understand its importance today. Join us on this exciting tour of A-366,833 and discover everything there is to know about this irresistible phenomenon.
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C11H12N4 |
Molar mass | 200.245 g·mol−1 |
3D model (JSmol) | |
Melting point | 101.4–102.9 °C (214.5–217.2 °F) |
| |
| |
(what is this?) (verify) |
A-366,833 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors selective for the α4β2 subtype, and has been researched for use as an analgesic, although it has not passed clinical trials. Its structure has a nicotinonitrile (3-cyanopyridine) core bound through C5 to the N6 of (1R,5S)-3,6-diazabicycloheptane.